Overview

Bioequivalence Study of Generic Leflunomide 20 mg Film-coated Tablets and Reference Product Under Fasting Conditions

Status:
NOT_YET_RECRUITING

Trial end date:
2024-04-26

Target enrollment:

Participant gender:

Summary

This Study Aims to Assess the Relative Bioavailability, Including the Rate and Extent of Absorption, of 20 mg Leflunomide Tablets Compared to ARAVA® 20 mg Tablets. The Evaluation Will be Conducted Following a Single Oral Dose (1 x 20 mg Tablet) in Healthy Thai Male Volunteers Under Fasting Conditions.

Phase:

PHASE1

Details

Lead Sponsor:

International Bio service

Treatments:

Leflunomide